Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome

Abstract Diffuse gliomas are classified according to the 2016 WHO Classification of Tumors of the Central Nervous System, which now defines entities by both histology and molecular features. Somatostatin receptor subtype 2A (SSTR2A) expression has been reported in various solid tumors as associated...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Romain Appay, Emeline Tabouret, Mehdi Touat, Catherine Carpentier, Carole Colin, François Ducray, Ahmed Idbaih, Karima Mokhtari, Emmanuelle Uro-Coste, Caroline Dehais, Dominique Figarella-Branger, the POLA network
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2018-09-01
coleção:	Acta Neuropathologica Communications
Assuntos:	Somatostatin receptor subtype 2A (SSTR2A) Glioma Biomarker Therapeutic target
Acesso em linha:	http://link.springer.com/article/10.1186/s40478-018-0594-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!